Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

PepsiCo (PEP) To Acquire KeVita, Foray Beyond Soda Drinks

Published 11/23/2016, 07:52 AM
Updated 07/09/2023, 06:31 AM

PepsiCo Inc. (NYSE:PEP) has agreed to acquire a sparkling probiotic U.S. drinks company KeVita, thereby diversify its soft drinks portfolio amid slowing soda sales.

Although the company did not disclose the financial terms of the deal, Fortune reports reveal that the transaction will be worth around $200 million.

Acquisition Details

Founded in 2010, KeVita’s products include sparkling probiotics, master brew kombucha tea and vinegar tonics. It is important to note here that probiotics mainly help the digestive and immune health. At present, PepsiCo has Naked Juice and O.N.E Coconut Waters as healthier offerings in its portfolio.

KeVita markets its products as: “Pure and organic beverages that support digestive health and immune function.”

Meanwhile, growing health and wellness consciousness is hurting carbonated soft drinks or CSD category growth. Consumers are particularly vigilant about the use of artificial sweeteners, high sugar content and related obesity concerns.

Among CSDs, the cola segment was particularly dealt a blow as consumers are opting for alternative beverage offerings. The diet colas are also under pressure due to increasing consumer concern regarding the use of artificial sweeteners.

Also, potential new taxes on sugar-sweetened beverages and growing regulatory pressure are denting CSD sales. The challenges in the CSD category have been felt by all major soft drink makers – The Coca-Cola Company (NYSE:KO) , Pepsi and Dr Pepper Snapple Group, Inc. (NYSE:DPS) – leading to lower volumes and weak sales.

Though PepsiCo has increased marketing investments and is driving package and product innovation to boost the carbonated beverage business, no meaningful improvement has been seen yet. The company’s CSD volumes declined 2% each in 2014 and 2015 and 3% in the first nine months of 2016.

Hence, addition of KeVita will expand PepsiCo’s health and wellness offerings in the premium chilled beverage space.

Meanwhile, in a separate news release, Dr Pepper has agreed to take over Bai Brands, LLC ("Bai") as well as its entire portfolio of high-growth premium antioxidant-infused beverages in order to expand into the low-calorie beverage market. So it is quite obvious that these beverage giants are ramping up their alternative beverage offerings in the face of declining soda sales.

Zacks Rank & Key Picks

PepsiCo holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

A better-ranked beverage stock is Coca-Cola Amatil Limited (OTC:CCLAY) .

For Coca-Cola Amatil, full-year 2016 earnings growth is expected at 10.8% and the stock carries a Zanks Rank #2.

"Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>"

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


COCA COLA CO (KO): Free Stock Analysis Report

DR PEPPER SNAPL (DPS): Free Stock Analysis Report

PEPSICO INC (PEP): Free Stock Analysis Report

COCA-COLA AMATI (CCLAY): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.